Hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer: The Cleveland Clinic experience

被引：0
|
作者：
Costales, A. B. [1 ]
Chambers, L. Moulton [2 ]
Chichura, A. M. [1 ]
Rose, P. G. [2 ]
Mahdi, H. [1 ]
Michener, C. M. [1 ]
Yao, M. [1 ]
DeBernardo, R. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2449
引用
收藏
页码：257 / 258
页数：2
相关论文
共 50 条
  • [31] Hyperthermic intraperitoneal chemotherapy (HIPEC)
    Cervantes-Zamora, Antonio
    Sanchez-Prieto, Mario
    Felix-Guzman, Ulises
    Orozco-Orduna, Carlos U.
    Madrigal-Perez, Violeta M.
    GACETA MEXICANA DE ONCOLOGIA, 2022, 21 : 102 - 104
  • [32] Transcriptomic analysis of hyperthermic intraperitoneal chemotherapy (HIPEC) in a cellular model of ovarian cancer
    Horowitz, M. P.
    Esakov, E. L.
    Hong, C.
    Michener, C. M.
    Rose, P. G.
    Hwang, T. H.
    DeBernardo, R.
    Reizes, O.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 154 - 155
  • [33] HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH PRIMARY OR INTERVAL CYTOREDUCTIVE SURGERY IN THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN CANCER
    Vatansever, Dogan
    Giray, Burak
    Donmez, Emin Erhan
    Balik, Emre
    Arslan, Tonguc
    Arvas, Macit
    Taskiran, Cagatay
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A332 - A333
  • [34] Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer Comment
    Wethington, Stephanie L.
    Armstrong, Deborah K.
    Johnston, Fabian M.
    JAMA SURGERY, 2022, 157 (05) : 383 - 383
  • [35] Influence of hyperthermic intraperitoneal chemotherapy (HIPEC) on morbidity and start of adjuvant chemotherapy in patients with ovarian cancer
    Friedrich, M.
    Altgassen, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 695 - 695
  • [36] Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian cancer. Importance and current trials
    Keyver-Paik, M. -D.
    Abramian, A.
    Maass, N.
    Kuhn, W.
    GYNAKOLOGE, 2015, 48 (07): : 549 - 552
  • [37] Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer
    Behbakht, Kian
    Cohn, David E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 4 - 5
  • [38] Ovarian cancer survival outcomes of debulking surgery in the hyperthermic intraperitoneal chemotherapy (HIPEC) era
    Bell, Sarah
    Sukumvanich, Paniti
    Rush, Shannon
    Berger, Jessica
    Edwards, Robert
    Buckanovich, Ronald
    Mahdi, Haider
    Lesnock, Jamie
    Olawaiye, Alexander
    Courtney-Brooks, Madeleine
    Garrett, Alison
    Lin, Jeff
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S327 - S328
  • [39] Establishment of a standard operating procedure for management of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for epithelial ovarian cancer: an Irish experience
    Thompson, Claire
    Corry, Edward
    Glennon, Kate
    Mcvey, Ruaidhri
    Walsh, Tom
    Broderick, Sheilah
    Murphy, Fiona
    Khan, Faraz
    Shields, Conor
    Mulsow, Jurgen
    Brennan, Donal
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A368 - A368
  • [40] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer: A Review of the Current Literature
    Zirak-Schmidt S.
    Verwaal V.J.
    Indian Journal of Gynecologic Oncology, 2018, 16 (3)
12345